Get Ready for Action: Exact Sciences Takes the Stage at the Must-Attend Investor Conference of September 2023!

Breaking News from Madison, Wisconsin! Exact Sciences Corp. (Nasdaq: EXAS), the trailblazing leader in cancer screening and diagnostic tests, is gearing up for an electrifying event. Brace yourself for an exclusive opportunity to dive into the world of cutting-edge healthcare.

On September 12, 2023, mark your calendars, because it’s going down at the prestigious Baird Global Healthcare Conference in the heart of New York. Join us for a riveting fireside chat, where our company’s top brass will take the stage, starting at 10:50 a.m. Eastern Time.

But here’s the best part: You don’t have to be in the Big Apple to be part of this pivotal moment. We’re rolling out the red carpet to welcome investors from around the globe to join us via webcast. This isn’t just an event; it’s a front-row seat to the future of healthcare. Don’t miss out!

About Exact Sciences Corp.

At Exact Sciences, we’re not just a company; we’re a beacon of hope in the fight against cancer. As pioneers in the field of cancer screening and diagnostics, we don’t just provide tests; we offer the power of clarity.

Imagine having the information you need to take life-altering steps sooner, to make decisions that matter when they matter most. That’s what we’re all about.

Our track record speaks for itself, with game-changers like the Cologuard® and Oncotype® tests. But we’re not stopping there; we’re investing heavily in our innovation pipeline. Why? Because we’re on a mission to create revolutionary solutions that span the entire cancer journey – from prevention and early detection to treatment and beyond.

We’re not just changing the game; we’re rewriting the rules of engagement with cancer. Join us on this extraordinary quest to redefine what’s possible in healthcare.

Leave a Comment